Canadian Marijuana Stock in Fresh Trouble

Should cannabis investors buy the dip on Namaste Technologies Inc (TSXV:N) stock as new problems surface?

| More on:
Road sign warning of a risk ahead

Image source: Getty Images.

Just when the marijuana stock seemed to have weathered a negative revenue-growth streak, discouraging news keeps coming out of Namaste Technologies (TSXV:N). The latest news release may make concerned investors decide to completely stay away from the cannabis retailer’s ticker for a longer while.

The company’s press statement of March 5 was loaded with some scary stuff.

Reputable auditor resigns

Namaste’s new auditor PricewaterhouseCoopers LLP (PwC) has resigned after just five months on the job! PwC was appointed auditor at Namaste in September last year after a previous auditor was fired by the company for no disclosed reason.

The company revealed that PwC “resigned on its own initiative” and the audit firm “did not complete an audit of the corporation since its appointment.”

While it is stated that PwC has nothing material to report concerning its voluntary resignation from the job, investors shouldn’t take auditor resignations lightly, especially one that happens when a newly appointed auditor could not complete its first-ever year-end audit and leaves right in the middle of it.

The reason for the resignation remains a subject of speculation. There could have been some conflict on the application of accounting rules and reporting standards or other grave issues, like financial mismanagement or worse, but until such issues surface later, investors may remain skeptical of the company’s financial performance and status of internal affairs.

Naturally, an accounting firm won’t typically resign from a lucrative client, unless if their priced reputation is at stake, or there is another very good reason. Whatever the reason, an auditor’s resignation may imply some severe problems in a listed company.

Potential failure to report

The company says that it may fail to file annual financial statements by the March 31, 2019, regulatory deadline.

The potential deadline miss may be related to the untimely departure of an auditor before the conclusion of financial audits for the fiscal year, and the company is in the process of finding a new auditor who will also take some time to go through the review process.

Whatever the reason for missing a filing deadline is, this is a bad incident that further damages a company’s reputation, or what’s left of it, after previous reports of insider self-dealing and breaches of fiduciary duty by the CEO concerning a sold U.S. subsidiary were confirmed by the company recently.

Legal counsel lapses?

After recent management changes, the company is thoroughly reviewing its businesses to ensure strategic focus and full compliance with local market laws in its global e-commerce businesses.

Compliance issues are material to the stock as any breaches may attract hefty fines and business activity bans. Such reviews are critical, and are usually done before business launches, after which continuous monitoring commences. Could there have been some lapses in the firm’s legal counsel?

Then some regulatory breach in Brazil…

Some irregular tobacco product adverts were reportedly flown on the company’s online store in Brazil, and the regulator there is about to take some action against the company. In response, Namaste has suspended its store’s operations while taking corrective action.

The Brazilian market contributed 8% to Namaste’s revenue for the 15 months to November 2018, and this market remains an important growth front to the company.

Generally, being on a national regulator’s bad side isn’t a good thing, and the situation could sometimes get worse in an emerging economy.

Foolish bottom line

Namaste is making a history of trouble, and the recent skirmishes with its former CEO Sean Dollinger are still fresh in the investor’s notebook. Although a settlement and cease-fire arrangement were entered with the founding CEO after internal investigations incriminated him, equity investors have suffered the brunt through a tanking share price.

Management’s focus on regulatory compliance and the ongoing strategic business review are welcome, but the exercises paint a hazy picture of the firm’s corporate governance controls and procedures.

Contrarian investors may be tempted to buy the dip on the stock, and there are potential massive recovery gains here, but I would urge caution. Untimely auditor resignations and frequent auditor changes are serious red flags that may signal a high-risk client and paint a gloomy earnings outlook.

Beware the magnified investment risk!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »